Clinical Trial Update: Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating Helicobacter pylori eradication therapy in patients with immune thrombocytopenic purpura has completed. The update does not provide e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection
• Immune Thrombocytopenic Purpura

Snippet

Sponsor: Federal University of São Paulo | Conditions: Immune Thrombocytopenic Purpura, Helicobacter Pylori Infection | Phase 2, Phase 3 | Status: COMPLETED